Schedule 13G ownership disclosure

CONDUIT PHARMACEUTICALS INC

Common Stock, $0.0001 par value · CUSIP: 20678X106

Event date: 2025-01-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nirland Limited

    Shares: 15,350,000.00 · Class: 9.979%

  • Stockton Limited

    Shares: 15,350,000.00 · Class: 9.979%

  • The Rowland Master Trust

    Shares: 15,350,000.00 · Class: 9.979%

  • Dovet Limited

    Shares: 15,350,000.00 · Class: 9.979%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-005052
Form type
SCHEDULE 13G
Filer
CDT Equity Inc.
CIK
CIK 1896212
Filed
Jan 21, 2025
Reporting period
Jan 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub